Compare NVS & MS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NVS | MS |
|---|---|---|
| Founded | 1895 | 1924 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 266.5B | 278.0B |
| IPO Year | 1991 | N/A |
| Metric | NVS | MS |
|---|---|---|
| Price | $141.96 | $184.60 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 5 | 14 |
| Target Price | $118.00 | ★ $174.92 |
| AVG Volume (30 Days) | 1.5M | ★ 5.2M |
| Earning Date | 01-30-2026 | 01-15-2026 |
| Dividend Yield | 1.82% | ★ 2.13% |
| EPS Growth | N/A | ★ 48.48 |
| EPS | 7.30 | ★ 9.75 |
| Revenue | $56,372,000,000.00 | ★ $68,532,000,000.00 |
| Revenue This Year | $9.38 | $17.58 |
| Revenue Next Year | $2.69 | $5.75 |
| P/E Ratio | $19.49 | ★ $19.26 |
| Revenue Growth | 12.88 | ★ 17.59 |
| 52 Week Low | $97.39 | $94.33 |
| 52 Week High | $142.58 | $188.82 |
| Indicator | NVS | MS |
|---|---|---|
| Relative Strength Index (RSI) | 71.49 | 63.03 |
| Support Level | $135.55 | $177.14 |
| Resistance Level | $139.45 | $188.82 |
| Average True Range (ATR) | 1.57 | 3.27 |
| MACD | 0.24 | 0.28 |
| Stochastic Oscillator | 80.03 | 74.57 |
Novartis develops and manufactures innovative drugs. Key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States comprising close to one third of total revenue.
Morgan Stanley is a massive global financial services firm, with offices in 42 countries and more than 80,000 employees as of year-end 2024. The firm cut its teeth in investment banking and institutional trading, where it maintains a strong presence today, but generates the lion share of its income from wealth and asset management franchises, where it boasted $7.9 trillion in client assets at the end of its most recent fiscal year. After reincorporation as a bank holding company in the wake of the global financial crisis, Morgan Stanley also boasts a top 10 banking franchise by deposits, with nearly $400 billion in customer deposits, predominately attributable to cash sweeps from its wealth management and brokerage businesses.